Works matching IS 0008543X AND DT 2003 AND VI 98

Results: 354
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Salvage therapy in patients with glioblastoma.

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 12, p. 2678
    By:
    • Peter Hau;
    • Ulrike Baumgart;
    • Katharina Pfeifer;
    • Anne Bock;
    • Tanya Jauch;
    • Jörg Dietrich;
    • Klaus Fabel;
    • Oliver Grauer;
    • Caecilia Wismeth;
    • Monika Klinkhammer-Schalke;
    • Michael Allgäuer;
    • Gerhard Schuierer;
    • Horst Koch;
    • Juergen Schlaier;
    • Winfried Ulrich;
    • Alexander Brawanski;
    • Ulrich Bogdahn;
    • Andreas Steinbrecher
    Publication type:
    Article
    17
    18

    Prophylactic oophorectomy.

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 12, p. 2599
    By:
    • Peter W. Schlosshauer;
    • Carmel J. Cohen;
    • Frederique Penault-Llorca;
    • Carlos R. Miranda;
    • Yves-Jean Bignon;
    • Jacques Dauplat;
    • Liane Deligdisch
    Publication type:
    Article
    19

    Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies (Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the State of Nebraska or the Nebraska Department of Health and Human Services.)

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 12, p. 2607
    By:
    • Isabelle H. Roland;
    • Wan-Lin Yang;
    • Dong-Hua Yang;
    • Mary B. Daly;
    • Robert F. Ozols;
    • Thomas C. Hamilton;
    • Henry T. Lynch;
    • Andrew K. Godwin;
    • Xiang-Xi Xu
    Publication type:
    Article
    20
    21
    22

    Free interferon-α/β receptors in the circulation of patients with adenocarcinoma (Reagents were supplied by Dr. Mark Tepper (Ares-Serono Group, Randolph, MA) and Dr. Danielle Novick (The Weizmann Institute of Science, Rehovot, Israel).) Barbara Hudson, Reprints Coordinator, Fax: (201) 748-6021; E-mail: bhudson@mail.acponline.org (100 copies minimum).)

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 12, p. 2730
    By:
    • Julian L. Ambrus;
    • Wlodzimierz Dembinski;
    • Donald E. Sykes;
    • Selina Akhter;
    • Mahmoud N. Kulaylat;
    • Abul Islam;
    • Kailash C. Chadha
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    Author reply.

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 12, p. 2737
    By:
    • Lisa A. Newman
    Publication type:
    Article
    31
    32
    33

    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony-stimulating factor support in patients with hormone-refractory prostate carcinoma (The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.)

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 12, p. 2592
    By:
    • William K. Oh;
    • Susan Halabi;
    • W. Kevin Kelly;
    • Cary Werner;
    • Paul A. Godley;
    • Nicholas J. Vogelzang;
    • Eric J. Small
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    Cancer Medicine 6.

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 11, p. 2521
    By:
    • Maurie Markman
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome–related Kaposi sarcoma(Performed on behalf of the Gruppo Italiano Cooperativo AIDS & Tumori (GICAT) and the Italian Cohort of Naive Antiretroviral Patients (ICONA) study groups.)The following are members of the GICAT: Daniele Bernardi, Massimiliano Berretta, Roberta Cinelli, Giampiero di Gennaro, Mariagrazia Michieli, Isabella Milan, Maurizio Rupolo, Ornella Schioppa, Cecilia Simonelli, Michele Spina, Giuseppe Vultaggio, and Martina Zanetti (Aviano, Italy); Pierluigi Blanc (Bagno Ripoli, Italy); Giampiero Carosi and Massimo Puoti (Brescia, Italy); Giuliano Rizzardini and Claudia Zeroli (Busto Arsizio, Italy); Benedetto M. Celesia and Luciano Nigro (Catania, Italy); Ampelio Tocchetti (Como, Italy); Angelo Pan (Cremona, Italy); Francesco Mazzotta (Florence, Italy); Sante Grisorio (Foggia, Italy); Paolo Tundo (Galatina, Italy); Adriana Albini (Genoa, Italy); Marco Fasan, Giuseppe Landonio, Adriano Lazzarin, Carla Pastecchia, and Annalisa Ridolfo (Milan, Italy); Alberto Dolara (Monza, Italy); Vincenzo Montesarchio (Naples, Italy); Pietro L. Garavelli (Novara, Italy); Francesco Di Lorenzo and Salvatrice Mancuso (Palermo, Italy); Guido Chichino and Renato Maserati (Pavia, Italy); Daniela Padrini (Piacenza, Italy); Beatrice Adriani (Prato, Italy); Carla Lovigu (Sassari, Italy); Saverio Di Lorenzo (Sondalo, Italy); Ivano Dal Conte, Ezio Nigra, Filippo Lipani, and Alessandro Sinicco (Turin, Italy); Palma Delle Foglie (Trento, Italy); Alberto Vaglia (Treviso, Italy); Pierluigi Viale (Udine, Italy); and Enzo Raise (Venice, Italy).)

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 11, p. 2440
    By:
    • Guglielmo Nasti;
    • Ferdinando Martellotta;
    • Massimiliano Berretta;
    • Maurizio Mena;
    • Marco Fasan;
    • Giovanni Di Perri;
    • Renato Talamini;
    • Gabriella Pagano;
    • Maria Montroni;
    • Roberta Cinelli;
    • Emanuela Vaccher;
    • Antonella D'Arminio Monforte;
    • Umberto Tirelli
    Publication type:
    Article
    48

    Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer(The following members of the European Society of Medical Oncology Taskforce on Palliative and Supportive Care participated in this study: Maurizio Tonato (Policlinico Divisione Oncologia Medica, Perugia, Italy); K. Winand Lange (Johanniter–Krankenhaus Rheinhausen, Duisburg, Germany); Herbert Kappauf (Institut für Medizinische Onkologie, Nürnberg, Germany); Alexandru–Calin Grigorescu (Oncologic Institute of Bucharest, Bucarest, Romania); Sergei Tjulandin (Cancer Research Center, Moscow, Russia); Piotr Siedlecki (Marie Skledowska–Curie Institute Cancer Center, Warszawa, Poland); Marco Maltoni (Department of Medical Oncology, Pierantoni Hospital, Forlfi, Italy); Marianne Kloke (Universitätsklinikum Essen, Essen, Germany); Kaija Holli (Department of Oncology, University Hospital, Tampere, Finland); Vladimir Bryuzgin (Cancer Research Center, Moscow, Russia); Dirk Schrijvers (Middelheim Hospital, Antwerp, Belgium); Ozgur Ozyilkan (Baskent University Faculty of Medicine, Ankara, Turkey); Martin Chasen (Richard Eek Sandton Oncology Centre, Pretoria, South Africa); Maria Wagnerova (University Teaching Hospital, Kosice, Slovak Republic); Janos Szanto (Debrecen Medical University, Debrecen, Hungary); and Joao Oliveira (Istituto Portugues de Oncologia, Losboa Codex, Portugal).)

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 11, p. 2502
    By:
    • Nathan I. Cherny;
    • Raphael Catane
    Publication type:
    Article
    49

    Author reply.

    Published in:
    Cancer (0008543X), 2003, v. 98, n. 11, p. 2525
    By:
    • Allan Covens
    Publication type:
    Article
    50